Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
7
×
crispr
7
×
life sciences
national blog main
biotech
boston blog main
boston top stories
national
national top stories
san francisco blog main
abbvie
allergan
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
editas medicine
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
drugs
eli lilly
europe blog main
fda
gene editing
What
bio
roundup
crispr
gene
ceo
companies
editas
editing
experimental
medicines
month
new
therapeutics
therapy
abbvie
access
acquisitions
advanced
allergan
alliance
announced
approval
biogen’s
biopharma
biopharmaceutical
biotech
black
blessing
bosley
capacity
car
cell
check
clinical
collabs
congress
congressional
consolidation
continue
convo
Language
unset
Current search:
crispr
×
" clinical trials "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial